Press Releases
Bristol-Myers Squibb to Host Investor Teleconference to Discuss World Conference on Lung Cancer (WCLC) Highlights
Bristol-Myers Squibb Company (NYSE:BMY) will host a teleconference on Tuesday, September 8 at 8 a.m. EDT (6 a.m. MDT) to review data presented at...
Press Releases
coramaze technologies raises EUR 4.5 million to advance novel transfemoral mitral valve repair system into the clinic
Coramaze technologies GmbH, a German medical device company, is developing themitramaze® valve repair system – a novel concept for transcatheter mitral valve repair (TMVRep)...
Press Releases
Bristol-Myers Squibb Enters Agreement Providing Exclusive Right to Acquire Promedior, Inc. and its Novel PRM-151 in Development for Fibrotic Diseases
"PRM-151 will complement our growing early-stage fibrosis portfolio, and we are excited by its potential to address multiple fibrotic diseases." Bristol-Myers...
Press Releases
Bristol-Myers Squibb and QIMR Berghofer Medical Research Institute Announce Worldwide Collaboration to Discover Novel Immuno-Oncology Antibodies
"We are excited to work with QIMR Berghofer Medical Research Institute, a partner that brings significant experience and expertise in cancer research." ...
Press Releases
Lilly To Participate In Morgan Stanley Global Healthcare Conference
Eli Lilly and Company (NYSE: LLY) will attend the Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015. Sue Mahony, Ph.D., senior vice...
Press Releases
U.S. Food and Drug Administration Accepts for Priority Review the Biologics License Application for Empliciti (elotuzumab) for the Treatment of Multiple Myeloma in Patients...
This acceptance for review marks the first in the U.S. for a SLAMF7-directed immunostimulatory antibody "AbbVie is encouraged by the...
Press Releases
U.S. District Court Rules In Lilly’s Favor On Alimta Vitamin Regimen Patent
Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company's...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read